Decagonal pKPL: shaping up to transplant success

Article

Using a decagonal transplant shape in perforating keratoplasties (pKPL) delivers promising results.

Using a decagonal transplant shape in perforating keratoplasties (pKPL) delivers promising results, says Mark Tomalla from the Clinic for Refractive and Ophthalmic Surgery, Duisburg, Germany.

Dr Tomalla and colleagues have performed 30 pKPL procedures using the Femtec femtosecond laser (20/10 Perfect Vision) over the past two years and have been satisfied with the postoperative results. As a further development, however, the researchers wanted to investigate the optimal transplant shape.

Three pKPL procedures with a decagonal transplant shape have so far been carried out, demonstrating a fit precision of 1/100 mm on the recipient cornea. After two months mean astigmatisms were 2 D and have remained stable since. Fine Descemet folds were visible immediately after surgery but these disappeared after approximately two weeks.

Dr Tomalla believes that the use of non-circular transplant shapes, such as the decagonal shape, is a promising approach to pKPL.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.